Low-molecular-weight or unfractionated heparin in venous thromboembolism: The influence of renal function

American Journal of Medicine

Volumn 126, Issue 5, 2013, Pages

  Trujillo Santos, Javier ^a   Schellong, Sebastian ^b   Falga, Conxita ^c   Zorrilla, Vanessa ^d   Gallego, Pedro ^e   Barrón, Manuel ^f   Monreal, Manuel ^g  

^a Hospital Universitario de Santa Lucia   (Spain)

^b ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

^c HOSPITAL DE MATARÓ   (Spain)

^d HOSPITAL TXAGORRITXU   (Spain)

^e HOSPITAL DE JEREZ   (Spain)

^f HOSPITAL SAN PEDRO   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Low molecular weight heparin; Mortality; Renal insufficiency; Unfractionated heparin; Venous thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84876297544     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.09.021     Document Type: Article

References (21)

1. C. Kearon, E.A. Akl, A.J. Comerota Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S
2. A. Torbicki, A. Perrier, S. Konstantinides ESC Committee for Practice Guidelines Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur Heart J 29 2008 2276 2315
3. N. Falvo, C. Bonithon-Kopp, K. Rivron Guillot Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry J Thromb Haemost 9 2011 1761 1768
4. W. Lim, F. Dentali, J.W. Eikelboom, M.A. Crowther Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency Ann Intern Med 144 2006 673 684
5. H.L. Daneschvar, A. Seddighzadeh, G. Piazza, S.Z. Goldhaber Deep vein thrombosis in patients with chronic kidney disease Thromb Haemost 99 2008 1035 1039
6. R. Bauersachs, S.M. Schellong, S. Haas CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency Thromb Haemost 105 2011 981 988
7. N. Thorevska, Y. Amoateng-Adjepong, R. Sabahi Anticoagulation in hospitalized patients with renal insufficiency A comparison of bleeding rates with unfractionated heparin vs enoxaparin Chest 125 2004 856 863
8. V. Farooq, J. Hegarty, T. Chandrasekar Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney disease Am J Kidney Dis 43 2004 531 537
9. M. Monreal, C. Falgá, R. Valle Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry Am J Med 119 2006 1073 1079
10. A. Leizorovicz, V. Siguret, D. Mottier Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep in Renal Insufficiency Study (IRIS) Thromb Res 128 2011 27 34
11. C. Kearon, S. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, A.J. Comerota Antithrombotic therapy for venous thromboembolic disease American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 454S 545S
12. J. Hirsh, K.A. Bauer, M.B. Donati, M. Gould, M.M. Samama, J.I. Weitz Parenteral anticoagulants American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 141S 159S
13. D.A. Garcia, T.P. Baglin, J.I. Weitz, M.M. Samama Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e24S e43S
14. C. Falgá, J.A. Capdevila, S. Soler Clinical outcome of patients with venous thromboembolism and renal insufficiency Findings from the RIETE Registry Thromb Haemost 98 2007 771 776
15. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
16. D. Jiménez, L. Moores, V. Gómez RIETE Investigators Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism Arch Intern Med 170 2010 1383 1389
17. P.M. Erkens, M.H. Mrins Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Cochrane Database Syst Rev 9 2010 CD001100
18. R.B. D'Agostino Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
19. G.M. Chertow, S.L. Normand, L.R. Silva, B.J. McNeil Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project Am J Kidney Dis 35 2000 1044 1051
20. G.M. Chertow, S.L. Normand, B.J. McNeil Renalism: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency J Am Soc Nephrol 15 2004 2462 2468
21. R.B. D'Agostino Propensity scores in cardiovascular research Circulation 115 2007 2340 2343